Ticker Symbol: ANTH
Anthera Pharmaceuticals Inc
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001316175
Company Profile
anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: anth
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 25801 Industrial Blvd Ste B
Website: http://www.anthera.com/
CEO: J. Craig Thompson
Tags:
- Biotechnology
- Health Technology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.00
Change:
-
(
0.00%)
Days Range: $0.00 - $0.00
Beta: -
52wk. High: $0.00
52wk. Low: $0.00
Ytd. Change 0.00%
50 Day Moving Average: $0.00
200 Day Moving Average: $0.00
Shares Outstanding: 26179302
Valuation
Market Cap: $2,618.00
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A